Literature DB >> 4190022

[Presence of a ferroprotein of tissue origin, the alpha-2H globulin, in sera of children with tumors].

D Buffe, C Rimbaut, J Lemerle, O Schweisguth, P Burtin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4190022     DOI: 10.1002/ijc.2910050111

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  8 in total

Review 1.  Clinical value of tumour-associated antigens.

Authors:  A M Neville
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1974

2.  A biochemical comparison of normal human liver and hepatocellular carcinoma ferritins.

Authors:  S Bullock; A Bomford; R Williams
Journal:  Biochem J       Date:  1980-03-01       Impact factor: 3.857

3.  [Carcinofetal antigens. III. Further carcinofetal antigens (author's transl)].

Authors:  R Lamerz; A Fateh-Moghadam
Journal:  Klin Wochenschr       Date:  1975-05-01

4.  Immunosuppresive effect of a human hepatic glycoferroprotein, alpha2H globulin. A study on the transformation of normal human lymphocytes.

Authors:  D Buffe; C Rimbaut
Journal:  Immunology       Date:  1975-07       Impact factor: 7.397

5.  Clinicopathological role of tumour index substances in paediatric neoplasia.

Authors:  A M Neville; K Grigor; E Heyderman
Journal:  J Clin Pathol       Date:  1976-11       Impact factor: 3.411

6.  The possible role of the carcinoembryonic antigen (CEA) and other carcinofetal antigens in maligant and benign diseases of the gastrointestinal tract.

Authors:  S von Kleist
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1977-10

Review 7.  Foetal antigens and their role in the diagnosis and clinical management of human neoplasms: a review.

Authors:  D J Laurence; A M Neville
Journal:  Br J Cancer       Date:  1972-10       Impact factor: 7.640

8.  An antigen associated with mesenchyme in human tumours that cross-reacts with brain glycoprotein.

Authors:  B Delpech; A Delpech; N Girard; C Chauzy; R Laumonier
Journal:  Br J Cancer       Date:  1979-07       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.